Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 130 Results

Title
Intervention Indication Therapeutic Area Year Actions
Durvalumab in combination with Tremelimumab for locally advanced or metastatic urothelial bladder cancer – first line Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) , Tremelimumab (CP-675206; CP-675 206) Bladder cancer Urological Cancer 2017 View  |  Download
Durvalumab (Imfinzi) monotherapy for advanced or metastatic non-small cell lung cancer (EGFR and ALK wild type) – first line Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2017 View  |  Download
Durvalumab (Imfinzi) for locally advanced or metastatic urothelial bladder cancer – first line Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) Bladder cancer Urological Cancer 2017 View  |  Download
Domagrozumab (PF-6252616) for Duchenne muscular dystrophy in children and adolescents Domagrozumab (PF-06252616) Duchenne muscular dystrophy (DMD) Genetic Disorders , Musculoskeletal System 2017 View 
Denosumab for the prevention of skeletal related events in patients with multiple myeloma – first line Denosumab (AMG 162; Prolia; Xgeva) Prevention of skeletal related events in multiple myeloma Haematological Cancer and Lymphomas , Musculoskeletal System 2017 View  |  Download
Dasatinib (Sprycel) tablets for children with type II variation, philadelphia positive acute lymphoblastic leukaemia Dasatinib (Sprycel; BMS 354825; dasatinib monohydrate) Acute lymphoblastic leukaemia (ALL) Haematological Cancer and Lymphomas 2017 View  |  Download
Darbepoetin alfa (Aranesp) for treatment of anaemia in adults with low or intermediate-1-risk myelodysplastic syndromes Darbepoetin alfa (Aranesp) Anaemia Haematology 2017 View  |  Download
Daratumumab (Darzalex) with lenalidomide and dexamethasone for multiple myeloma – first line Daratumumab (Darzalex; JNJ-54767414) , Dexamethasone (dexamethasone sodium metasulfobenzoate) , Lenalidomide (Revlimid) Multiple myeloma (MM) Haematological Cancer and Lymphomas 2017 View  |  Download
Dabigatran Etexilate (Pradaxa) for Secondary Stroke Prevention in Patients with Embolic Stroke of Undetermined Source – First Line Dabigatran etexilate (Pradaxa) Ischaemic stroke Cardiovascular System 2017 View  |  Download
Cysteamine bitartrate (Procysbi) delayed release for Huntington’s Disease Cysteamine bitartrate (Procysbi; RP103; Lynovex; NM001; Cystadrops; Mercaptamine) Huntington's disease Genetic Disorders , Neurology 2017 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications